Literature DB >> 32962862

Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells.

Thayane Crestani1, Clara Steichen1, Elida Neri1, Mariliza Rodrigues1, Miriam Helena Fonseca-Alaniz1, Beth Ormrod2, Mark R Holt2, Pragati Pandey3, Sian Harding3, Elisabeth Ehler2, Jose E Krieger4.   

Abstract

Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) resemble fetal cardiomyocytes and electrical stimulation (ES) has been explored to mature the differentiated cells. Here, we hypothesize that ES applied at the beginning of the differentiation process, triggers both differentiation of the hiPSC-CMs into a specialized conduction system (CS) phenotype and cell maturation. We applied ES for 15 days starting on day 0 of the differentiation process and found an increased expression of transcription factors and proteins associated with the development and function of CS including Irx3, Nkx2.5 and contactin 2, Hcn4 and Scn5a, respectively. We also found activation of intercalated disc proteins (Nrap and β-catenin). We detected ES-induced CM maturation as indicated by increased Tnni1 and Tnni3 expression. Confocal micrographs showed a shift towards expression of the gap junction protein connexin 40 in ES hiPSC-CM compared to the more dominant expression of connexin 43 in controls. Finally, analysis of functional parameters revealed that ES hiPSC-CMs exhibited faster action potential (AP) depolarization, longer intracellular Ca2+ transients, and slower AP duration at 90% of repolarization, resembling fast conducting fibers. Altogether, we provided evidence that ES during the differentiation of hiPSC to cardiomyocytes lead to development of cardiac conduction-like cells with more mature cytoarchitecture. Thus, hiPSC-CMs exposed to ES during differentiation can be instrumental to develop CS cells for cardiac disease modelling, screening individual drugs on a precison medicine type platform and support the development of novel therapeutics for arrhythmias.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; Electrical stimulation; Human induced pluripotent stem cells derived cardiomyocytes; Maturation; Specialized cardiac conduction cells

Year:  2020        PMID: 32962862     DOI: 10.1016/j.bbrc.2020.09.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Cardiomyocyte Maturation-the Road is not Obstructed.

Authors:  Yaning Wang; Miao Yu; Kaili Hao; Wei Lei; Mingliang Tang; Shijun Hu
Journal:  Stem Cell Rev Rep       Date:  2022-07-05       Impact factor: 5.739

2.  4D Printed Cardiac Construct with Aligned Myofibers and Adjustable Curvature for Myocardial Regeneration.

Authors:  Yue Wang; Haitao Cui; Yancheng Wang; Chengyao Xu; Timothy J Esworthy; Sung Yun Hann; Manfred Boehm; Yin-Lin Shen; Deqing Mei; Lijie Grace Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2021-01-06       Impact factor: 10.383

3.  Time-regulated transcripts with the potential to modulate human pluripotent stem cell-derived cardiomyocyte differentiation.

Authors:  Juan J A M Muñoz; Rafael Dariolli; Caio Mateus da Silva; Elida A Neri; Iuri C Valadão; Lauro Thiago Turaça; Vanessa M Lima; Mariana Lombardi Peres de Carvalho; Mariliza R Velho; Eric A Sobie; Jose E Krieger
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

4.  Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation.

Authors:  Homa Hamledari; Parisa Asghari; Farah Jayousi; Alejandro Aguirre; Yasaman Maaref; Tiffany Barszczewski; Terri Ser; Edwin Moore; Wyeth Wasserman; Ramon Klein Geltink; Sheila Teves; Glen F Tibbits
Journal:  Front Cardiovasc Med       Date:  2022-08-12

Review 5.  Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.

Authors:  Magali Seguret; Eva Vermersch; Charlène Jouve; Jean-Sébastien Hulot
Journal:  Biomedicines       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.